Detailed Analysis of Amphastar Pharmaceuticals Inc's Q1 2024 Financial Performance
Amphastar Pharmaceuticals ( NASDAQ:AMPH ) First Quarter 2024 Results Key Financial Results Revenue: US$171.8m (up 23...
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank ...